You Can Learn a Lot About Yourself From a DNA Test. Here's What Your Genes Cannot Tell You
By Libby Copeland,
TIME
| 03. 02. 2020
“Have you found an article of clothing with a suspicious stain?” asks the website of one Florida-based company called All About Truth DNA Services, which informs readers that “aprrpoximately [sic] 60% of husbands and 40% of wives will have an affair at some point,” and recommends consumers wait for their “suspicious item” to dry and then send it in for testing. Also accepted: cigarette butts, toothpicks, hair.
The landscape of the consumer genomics market now would have been barely recognizable a decade ago. One study by scholar Andelka Phillips, then at the University of Oxford, found that as of January 2016, at least 246 genetics testing companies across the globe were selling their wares directly to customers online. Not all DNA testing companies offer services related to predicting ethnicity and finding relatives; indeed, the spectrum of services they offer is dizzying, and their usefulness and accuracy sometimes dubious. They range from the paternity tests you can pick up at Walgreens to tests that look specifically for African or Native American ancestry to others promising DNA-based matchmaking services. Phillips’s survey placed...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...